2018.0: Sunday, October 21, 2001 - 12:11 PM

Abstract #32782

Cost containment of pharmaceutical issues under Medicare

Victor Freeman, MD, Medical Director, Quality & Outcomes Management, INOVA Health Systems, , victor.freeman@inova.com

Learning Objectives: See overall session

Keywords: Medicare, Cost Issues

Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: None
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.

The 129th Annual Meeting of APHA